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On December 13, 2008 the endocrine re-
search community suffered a sad loss
with the death of Keith Langston Parker,
distinguished professor in biomedical
research at the University of Texas (UT)
Southwestern Medical Center, who suc-
cumbed as a consequence of a major
heart attack suffered during his daily run
2 weeks earlier. I enjoyed Keith’s friend-
ship for 23 years, and had the privilege
of collaborating with him extensively
over that period. The essayist and philos-
opher William Hazlitt once noted that the
ability to sustain a steady friendship is
one of the greatest proofs of goodness
of heart and of greatness of mind. This
was certainly true for Keith, whose unas-
suming personality, sharp wit, and keen
mind made for an easy friendship and
productive collaboration.
Keith obtained his M.D. degree cum
laude at Washington University in
St. Louis, along with a Ph.D. degree in
immunogenetics in the laboratory of Don-
ald Shreffler. After completing an internal
medicineresidencyat theUTSouthwestern
Medical Center, Keith joined the laboratory
of Jonathan Seidman at Harvard University
for postdoctoral studies in molecular
biology. At the time, Seidman had isolated
a number of overlapping cosmid clones
from the S region of the mouse H2 histo-
compatibility complex. It was at this time
(in 1985) when I first began collaborating
with Keith. My lab had been interested in
the molecular genetics of adrenal steroido-
genesis, and when I had learned that
one of the genes involved
in adrenal steroidogenesis,
Cyp21, resided in this
S region, I had approached
Seidman for the relevant
cosmid clone in order to study
Cyp21 gene expression in our
adrenocortical cell lines. The
Seidman lab had not been
able to express Cyp21 in
fibroblast cells and so was
skeptical about the likelihood
of our success. Nevertheless,
Jonathan sent me one of
his cosmid clones, and I
was able to demonstrate that
it contained sufficient coding
information to direct the
expression of Cyp21 in an adrenal cell-
selective, hormone-responsive manner.
Keith and I then teamed up to identify the
promoter regulatory elements involved in
Cyp21 gene expression, thereby marking
the beginnings of Keith’s career as an
endocrinologist.
In 1987, Keith moved to the Department
of Medicine at Duke University as a Ho-
ward Hughes Medical Institute investi-
gator. It was at Duke that Keith initiated
a series of experiments that propelled
him to the forefront of endocrine research.
Keith and I continued our collaboration
and identified the promoter regulatory
elements required for the expression of
two other genes involved in steroidogen-
esis, Cyp11a1 and Cyp11b1. Through
these studies, we obtained the first hints
of a shared promoter regulatory element
required for the cell-selective expression
of Cyp21, Cyp11a1, and Cyp11b1. Keith
then carried out the definitive experiments
by cloning the transcription factor that
regulated the activity of this promoter
regulatory element. He went on to demon-
strate that this transcription factor, which
he named steroidogenic factor 1 (SF1)
was an orphan nuclear receptor of the
Ftz-F1 family of transcription factors, was
expressed in the major steroidogenic
tissues, and was involved in the coordi-
nate expression of several genes involved
in adrenal steroidogenesis. This discovery
led to his development of SF1 knockout
mice and the demonstration of extended
roles for SF1 in adrenal and gonadal devel-
opment and in the formation of the ventro-
medial hypothalamus.
In 1997, Keith returned to Dallas to
become chief of the Division of Endocri-
nology and Metabolism, professor of
internal medicine and pharmacology, and
the Wilson distinguished professor in
biomedical research at the UT South-
western Medical Center. In Dallas, Keith
developed tissue-specific SF1 knockout
mouse models to define the roles of SF1
in specific sites in the hypothalamic-pitui-
tary-steroidogenic gland axis, and he
collaborated with many investigators
around the world, generously sharing his
reagents, insights, and expertise. Most of
us who worked with Keith appreciated his
modesty, soft-spoken demeanor, keen
insight, and decisiveness. Keith was a
matter-of-factscientist who was highlyeffi-
cient and got straight to the point whether
he was conducting experiments, lecturing,
or writing and editing manuscripts.
Keith received several honors and
distinctions for his scientific work,
including the Ernst Oppenheimer award
from the Endocrine Society in 1996, the
British Endocrine Society’s Transatlantic
Medal in 2004, and the University Seal
from the University of Bologna in 2006.
He served as an editor for the 11th edition
of the leading pharmacology textbook,
Goodman and Gilman’s Pharmacologic
Basis of Therapeutics and had begun
work on the 12th edition before his death.
He took a leadership role in the Endocrine
Society, serving on the editorial boards
of three of the society’s jour-
nals and on the Annual
Meeting Steering Committee
(which he eventually chaired).
Keith also played an active
role in the Adrenal Cortex
Conference series, serving
on the program advisory
committee and co-organizing
the 2006 meeting in Boston,
MA. Keith’s greatest contribu-
tions in this setting were in
the support of junior faculty
and trainees. He helped
identify young independent
investigators with exciting
research programs to speak
at the conferences and
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Keith was devoted to his family and was
an avid fan of NCAA basketball, with
a special affinity for the Duke University
team. One of Keith’s favorite movies was
It’s a Wonderful Life. Although Keith’s
wonderful life ended too soon, his work
will endure, and those that he inspired
will keep his memory alive for a long
time. Keith is survived by his wife Linda;
his children, Kevin, Andrea, Emily, Caro-
line, and Christopher; his parents, Drs.
Charles and Mary Parker; and his four
siblings, Dr. Charles Parker, Dr. Christina
Parker, Dr. Kathy Ponder, and Sandy Bigg.
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